tiprankstipranks
Corvus Pharmaceuticals Inc (CRVS)
NASDAQ:CRVS
Holding CRVS?
Track your performance easily

Corvus Pharmaceuticals (CRVS) Financial Statements

540 Followers

Corvus Pharmaceuticals Financial Overview

Corvus Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.926; its P/E ratio is -9.64; Corvus Pharmaceuticals is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -40.22M$ -4.26M$ -6.25M$ -5.65M$ -5.56M
EBITDA$ -40.20M$ -4.09M$ -6.23M$ -5.62M$ -5.53M
Net Income Common Stockholders$ -40.22M$ -4.26M$ -5.70M$ -6.65M$ -6.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 41.65M$ 47.25M$ 22.13M$ 27.15M$ 32.17M
Total Assets$ 58.81M$ 64.56M$ 40.08M$ 45.55M$ 51.94M
Total Debt$ 354.00K$ 700.00K$ 1.04M$ 1.37M$ 1.69M
Net Debt$ -41.30M$ -46.55M$ -21.09M$ -25.77M$ -30.48M
Total Liabilities$ 46.41M$ 6.22M$ 6.72M$ 6.87M$ 7.65M
Stockholders Equity$ 12.41M$ 58.31M$ 33.38M$ 38.68M$ 44.29M
Cash Flow-
Free Cash Flow$ -6.32M$ -5.48M$ -5.16M$ -5.17M$ -5.43M
Operating Cash Flow$ -6.32M$ -5.48M$ -5.16M$ -5.17M$ -5.43M
Investing Cash Flow$ -3.89M$ -17.50M$ -7.00K$ -2.32M$ 17.55M
Financing Cash Flow$ 50.00K$ 30.37M--$ 335.00K
Currency in USD

Corvus Pharmaceuticals Earnings and Revenue History

Corvus Pharmaceuticals Debt to Assets

Corvus Pharmaceuticals Cash Flow

Corvus Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis